SF3B1 and myelodysplastic syndrome: To investigate the functional consequences of mutations in SF3B1, we used the CRISPR/Cas9 genome engineering method to introduce the hotspot K700E mutation in K562 cells, an erythroleukemia cell line commonly used as a model in MDS and AML [26, 34].